Far exceeding the whole year of last year! The Hong Kong stock buyback wave continues, what impact does it have?
Since the beginning of this year, the buyback scale in the Hong Kong stock market has increased significantly. The total repurchase amount has exceeded 180 billion Hong Kong dollars, while the total buyback amount for the whole of last year was over 120 billion Hong Kong dollars.
The大行 (GTJA) has lowered the target price of Wuxi Bio (02269.HK) to 14.6 yuan, while the new item continues to grow.
Guotai Junan issued a research report indicating that considering the geopolitical risks of Wuxi Bio (02269.HK), it revised down its adjusted net profit forecast for the years 2024 to 2026 to CNY 4.919 billion, CNY 5.623 billion, and CNY 6.738 billion, respectively, with earnings per share of CNY 1.18, CNY 1.35, and CNY 1.62. The target price was lowered to CNY 14.6, while maintaining a "shareholding" rating. The bank stated that Wuxi Bio's new projects continue to grow, and its non-COVID-19 business development is stable. The company maintains its full-year guidance for 2024 unchanged. The company will also continue to invest in overseas production capacity construction, with an estimated completion by 20.
September 4th share repurchases | Tencent, Meituan-W, etc. have all announced share repurchases, with Tencent spending 1.003 billion Hong Kong dollars.
According to the disclosure documents of hkex on september 5, tencent and meituan-w repurchased shares. 1. Tencent repurchased 2.69 million ordinary shares on september 4, involving 1.003 billion hong kong dollars, with a repurchase price ranging from 376.4 hong kong dollars to 371.2 hong kong dollars per share. Since the authorization resolution for repurchase was passed, the cumulative repurchase of securities has reached 0.139 billion shares, accounting for 1.474% of the number of shares issued at the time of the ordinary resolution. 2. Meituan-w on september
Stock Opportunity Tracking | Hang Seng Index Company: Newly added fast-inclusion rules to the Hong Kong Stock Connect Index; Autohome plans to repurchase up to 0.2 billion US dollars of shares.
On the same day, the three major internet giants deepened their interconnection; the Beige Book of the Federal Reserve: The number of regions with flat or declining economic activity has increased to 9; Guangdong Inv has obtained a commitment for HKD 3 billion in committed term loan financing.
Wuxi Bio spent HKD 59.8888 million on September 4 to repurchase 5.43 million shares.
Wuxi Bio (02269) announced that on September 4, 2024, the company will spend 59.8888 million Hong Kong dollars to repurchase 5.43 million shares at a repurchase price of HK$10.78-11.20 per share.
Mainland China speeds up the implementation of centralized procurement of new batches of high-value medical consumables based on volume
Shi Zihai, Deputy Director of the National Medical Insurance Administration, recently led a team to Tianjin to investigate the centralized procurement of high-value medical consumables by national institutions. He stated that efforts should be made to accelerate the progress of the new batch of centralized volume-based procurement of high-value medical consumables by national institutions, and to include high-value medical consumables such as cochlear implants in the procurement scope. The market for consumables and clinical characteristics should be fully considered, and a "one product, one strategy" approach should be studied to improve the procurement rules. At the same time, we should focus on the implementation of the fourth batch of consumable procurement and the follow-up procurement of selected results for artificial joints after the expiration of the agreement, to ensure that the selected products are admitted to hospitals in a timely manner, guide and urge medical institutions to give priority to th